Symbol Name ID |
Lmna
lamin A MGI:96794 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Abnormal lymphocyte physiology |
Decreased HDL cholesterol concentration |
Increased LDL cholesterol concentration |
Hypercholesterolemia |
Hyperlipidemia |
Hypertriglyceridemia |
Elevated circulating creatine kinase concentration |
Mildly elevated creatine kinase |
Elevated circulating alanine aminotransferase concentration |
Elevated circulating aspartate aminotransferase concentration |
Hyperglycemia |
Diabetes mellitus |
Insulin-resistant diabetes mellitus |
Type II diabetes mellitus |
Impaired glucose tolerance |
Hyperinsulinemia |
Insulin resistance |
Hepatic steatosis |
Aortic valve calcification |
Mitral valve calcification |
Decreased serum leptin |
Subcutaneous calcification |
Chondrocalcinosis |
Ectopic calcification |
Disease(s) Associated with LMNA | ||||||||||||||||||||||||
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | ||||||||||||||||||||||||
autosomal recessive Emery-Dreifuss muscular dystrophy 3 | ||||||||||||||||||||||||
congenital muscular dystrophy due to LMNA mutation | ||||||||||||||||||||||||
dilated cardiomyopathy 1A | ||||||||||||||||||||||||
Emery-Dreifuss muscular dystrophy | ||||||||||||||||||||||||
familial partial lipodystrophy type 2 | ||||||||||||||||||||||||
mandibuloacral dysplasia type A lipodystrophy | ||||||||||||||||||||||||
progeria | ||||||||||||||||||||||||
type 2 diabetes mellitus | ||||||||||||||||||||||||
Werner syndrome |
Mouse Phenotypes | homeostasis/metabolism phenotype |
impaired exercise endurance |
abnormal double-strand DNA break repair |
abnormal DNA replication |
decreased circulating carnitine level |
abnormal blood homeostasis |
decreased circulating glucose level |
hypoglycemia |
decreased circulating insulin level |
increased circulating insulin level |
decreased circulating leptin level |
increased circulating growth hormone level |
increased circulating ketone body level |
decreased circulating lactate level |
increased circulating LDL cholesterol level |
increased circulating cholesterol level |
decreased circulating triglyceride level |
increased circulating phosphate level |
increased circulating alanine transaminase level |
increased circulating alkaline phosphatase level |
increased circulating aspartate transaminase level |
increased circulating creatine kinase level |
decreased core body temperature |
pulmonary edema |
impaired glucose tolerance |
improved glucose tolerance |
decreased liver glycogen level |
insulin resistance |
increased circulating adiponectin level |
increased liver triglyceride level |
increased triglyceride level |
abnormal urine homeostasis |
enhanced exercise endurance |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor | ||||||||||||||||||||||||||||||||||
Lmnatm1.1Otin/Lmnatm1.1Otin | ||||||||||||||||||||||||||||||||||
Lmnatm1.1Vde/Lmnatm1.1Vde | ||||||||||||||||||||||||||||||||||
Lmnatm1Gbon/Lmnatm1Gbon | ||||||||||||||||||||||||||||||||||
Lmnatm1Rben/Lmnatm1Rben | ||||||||||||||||||||||||||||||||||
Lmnatm1Stw/Lmnatm1Stw | ||||||||||||||||||||||||||||||||||
Lmnatm2.1Gbon/Lmnatm2.1Gbon | ||||||||||||||||||||||||||||||||||
LmnaDhe/Lmna+ | ||||||||||||||||||||||||||||||||||
Lmnaem1Fenz/Lmna+ | ||||||||||||||||||||||||||||||||||
Lmnatm1.1Otin/Lmna+ | ||||||||||||||||||||||||||||||||||
Lmnatm1b(EUCOMM)Wtsi/Lmna+ | ||||||||||||||||||||||||||||||||||
Lmnatm1Stw/Lmna+ | ||||||||||||||||||||||||||||||||||
Lmnatm2.1Gbon/Lmna+ | * | |||||||||||||||||||||||||||||||||
Lmnatm1Bliu/Lmna+ Tg(Tek-cre)1Ywa/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|